PlainRecalls
FDA Drug Low Class III Ongoing

AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01

Reported: September 25, 2024 Initiated: August 24, 2024 #D-0659-2024

Product Description

AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01

Reason for Recall

Discoloration

Details

Units Affected
3,984 bottles
Distribution
Nationwide in the US
Location
Ambarnath

Frequently Asked Questions

What product was recalled?
AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01. Recalled by Rubicon Research Private Limited. Units affected: 3,984 bottles.
Why was this product recalled?
Discoloration
Which agency issued this recall?
This recall was issued by the FDA Drug on September 25, 2024. Severity: Low. Recall number: D-0659-2024.